361 related articles for article (PubMed ID: 10999117)
21. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
[TBL] [Abstract][Full Text] [Related]
22. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
[TBL] [Abstract][Full Text] [Related]
23. Use of botulinum toxin in the treatment of cervical dystonia.
Poewe W; Wissel J
Baillieres Clin Neurol; 1993 Apr; 2(1):179-85. PubMed ID: 8143072
[TBL] [Abstract][Full Text] [Related]
24. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
Grosse J; Kramer G; Jakse G
BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
[TBL] [Abstract][Full Text] [Related]
25. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
[TBL] [Abstract][Full Text] [Related]
26. Treatment of nonoccupational limb and trunk dystonia with botulinum toxin.
Quirk JA; Sheean GL; Marsden CD; Lees AJ
Mov Disord; 1996 Jul; 11(4):377-83. PubMed ID: 8813216
[TBL] [Abstract][Full Text] [Related]
27. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553
[TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic outcome of spasmodic torticollis].
Hasegawa O; Matsumoto S; Gondo G; Arita T; Iwasawa H
No To Shinkei; 2001 Jun; 53(6):547-50. PubMed ID: 11436339
[TBL] [Abstract][Full Text] [Related]
30. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
[TBL] [Abstract][Full Text] [Related]
31. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
[TBL] [Abstract][Full Text] [Related]
32. Development of resistance to botulinum toxin type A in patients with torticollis.
Greene P; Fahn S; Diamond B
Mov Disord; 1994 Mar; 9(2):213-7. PubMed ID: 8196686
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
[TBL] [Abstract][Full Text] [Related]
34. Quantitative electromyographical changes in cervical dystonia after treatment with botulinum toxin.
Fuglsang-Frederiksen A; Ostergaard L; Sjö O; Werdelin L; Winkel H
Electromyogr Clin Neurophysiol; 1998 Mar; 38(2):75-9. PubMed ID: 9553744
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin in the treatment of writer's cramp.
Behari M
J Assoc Physicians India; 1999 Jul; 47(7):694-8. PubMed ID: 10778589
[TBL] [Abstract][Full Text] [Related]
36. [Injection of botulinum toxin as a new treatment of torticollis].
Aquilonius SM; Cesarini KG; Stålberg E
Lakartidningen; 1990 Dec; 87(51-52):4408-10. PubMed ID: 2177127
[TBL] [Abstract][Full Text] [Related]
37. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
Guettard E; Roze E; Abada G; Lemesle C; Vidailhet M; Laurent-Vannier A; Chevignard MP
Dev Neurorehabil; 2009 Jun; 12(3):128-38. PubMed ID: 19466620
[TBL] [Abstract][Full Text] [Related]
38. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials.
Lew MF; Brashear A; Factor S
Neurology; 2000; 55(12 Suppl 5):S29-35. PubMed ID: 11188982
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of spasmodic torticollis with local injections of botulinum toxin A].
Erbguth F; Kilian KD; Claus D; Neundörfer B
Dtsch Med Wochenschr; 1991 Apr; 116(15):567-72. PubMed ID: 2013263
[TBL] [Abstract][Full Text] [Related]
40. Long-term botulinum toxin efficacy, safety, and immunogenicity.
Mejia NI; Vuong KD; Jankovic J
Mov Disord; 2005 May; 20(5):592-7. PubMed ID: 15645481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
